Axmed

Axmed We believe access to medicines should be equal for all. We bring an innovative marketplace to empower emerging markets to access medicines more competitively.

Imagine a world where critical medicines are within reach, affordable, and synonymous with quality, no matter where you are. That's the world we're building with our unique, demand-aggregation model that unites healthcare providers across LMICs. At the heart of our identity is a resolute commitment: to build a future where geography and income never stand between any individual and life-saving med

icines. Our platform isn't merely a space for transactions, we unlock affordable access to medicines by aggregating demand across healthcare providers. We also help manufacturers build a sustainable and reliable global access strategy. Our business focuses on LMICs and strengthens the purchasing power of these markets to ensure the supply of cost-effective, high-quality medicines. We partner exclusively with authorized, high-quality pharmaceutical companies and certified caregivers to accelerate access to medicines.

In global health, every minute matters. When we noticed too much of our team’s time was being eaten up by repetitive, mu...
05/27/2026

In global health, every minute matters.

When we noticed too much of our team’s time was being eaten up by repetitive, multi-step tasks, we asked ourselves: what if you could just... ask?

In their latest tech blog, CTO Mattia Albergante and Senior Engineer Ángel Jiménez walk through how our tech team transformed a five-minute journey through multiple screens into a single natural language request to an AI.

If you’re building operational software, working in global health tech, or just thinking about what agentic AI actually looks like in production - this one is worth a read.

Read now at the link in our bio.

In global health, every minute matters. When we noticed too much of our team’s time was being eaten up by repetitive, mu...
05/27/2026

In global health, every minute matters.

When we noticed too much of our team’s time was being eaten up by repetitive, multi-step tasks, we asked ourselves: what if you could just... ask?

In his latest tech blog, CTO Mattia Albergante walks through how our tech team transformed a five-minute journey through multiple screens into a single natural language request to an AI.

If you’re building operational software, working in global health tech, or just thinking about what agentic AI actually looks like in production - this one is worth a read.

Read now at the link in our bio.

This week, team Axmed is on the ground in Geneva for the World Health Assembly.Over the past year, we’ve worked alongsid...
05/18/2026

This week, team Axmed is on the ground in Geneva for the World Health Assembly.

Over the past year, we’ve worked alongside governments, manufacturers, procurers, and partners to strengthen national procurement systems with greater transparency and efficiency.

Whether we're scaling technology-enabled procurement infrastructure, supporting country-led access models, or expanding innovative financing mechanisms for MNCH commodities, the focus remains the same: building systems that help quality-assured medicines reach the people who need them faster, more affordably, and at scale.

We’re looking forward to continuing these conversations at as part of our broader work to help create a future where public procurement systems are stronger, smarter, and built for scale.

Please reach out at [email protected] if you’d like to connect with the team on the ground.

One year ago at the World Health Assembly, we made a commitment.Together with the Gates Foundation, we launched a $10M c...
05/07/2026

One year ago at the World Health Assembly, we made a commitment.

Together with the Gates Foundation, we launched a $10M catalytic co-financing mechanism designed to strengthen public sector procurement capacity for quality-assured maternal, newborn, and child health (MNCH) commodities.

The model saw a 1:1 match on government procurement of MNCH commodities through the Axmed Medicines Platform, designed to help governments move further, faster, and with greater purchasing power.

Later this month, Team Axmed returns to Geneva with ex*****on already underway.

One year on:
🔹 Six governments are now fully active or in the process of onboarding
🔹 Quality-assured MNCH commodities are reaching frontline facilities

What began as a commitment is now translating into real procurement infrastructure, supporting governments to strengthen national systems with greater transparency, efficiency, and control.

As we head back to WHA, we’re looking forward to building on these conversations and continuing to push toward a future where public procurement systems are stronger, smarter, and built for scale.

When you’re building a marketplace designed to improve access to medicines, time matters.But moving fast can’t mean lowe...
04/22/2026

When you’re building a marketplace designed to improve access to medicines, time matters.

But moving fast can’t mean lowering standards. 

When we wanted to find a way to enforce quality standards more efficiently, without compromising rigor. We couldn’t find one, so we built one.

In her latest piece for our tech blog, our co-founder and COO Radley-Searle shares how we’re using AI to turn pharma audits into real-time quality intelligence.

The quality of reporting improved, became more consistent and more comprehensive. As Sofia explains: “What took days, and weeks, now takes minutes.” 

Delve into the details in Sofia’s full piece, where she explains what we built and why it matters at the link in our bio.

“The certificate was valid. The medicine was not.” 💬In this new piece, our Regulatory Affairs Manager, Dr. Onyango Micha...
04/01/2026

“The certificate was valid. The medicine was not.” 💬

In this new piece, our Regulatory Affairs Manager, Dr. Onyango Michael, explores a challenge that too often goes unspoken across medicine supply chains in East Africa: a system that rewards the appearance of quality, rather than its sustained delivery.

Dr. Onyango’s article reframes the issue as a system design challenge.

This piece lays out what needs to change, and where infrastructure can play a role in making quality visible, verifiable, and actionable across the full journey from manufacturer to patient.

Read the full article via the link in bio.

This week, our team was in Nairobi for the International Maternal and Newborn Health Conference (IMNHC), meeting with go...
03/27/2026

This week, our team was in Nairobi for the International Maternal and Newborn Health Conference (IMNHC), meeting with government leaders, pharmaceutical manufacturers, procurers, and partners for honest conversations on the future of medicines access across the region.

These conversations highlighted a central issue: the challenge with healthcare access isn’t supply. It’s coordination. 

On Monday, we brought that conversation into focus at an event we hosted exploring how technology can change this. Through technology-enabled procurement, pricing becomes transparent, and supply chains become more reliable and responsive.

Speakers brought this to life with real examples, from reduced costs to faster access and stronger alignment across the ecosystem.

No single actor can solve this. But the model is working. The focus now is scaling it.

Thank you to everyone who joined us and contributed to an open, candid dialogue on what comes next.

We’re honoured to have been named to Most Innovative Companies of 2026, ranked #2 in Healthcare globally! 🚀We’re incre...
03/24/2026

We’re honoured to have been named to Most Innovative Companies of 2026, ranked #2 in Healthcare globally! 🚀

We’re incredibly proud of this moment, and remain laser-focused on what comes next.

To our team, partners, and everyone building alongside us: thank you. We’re just getting started. 🎉

Each year, hundreds of thousands of children across sub-Saharan Africa die from infections that are both preventable and...
03/19/2026

Each year, hundreds of thousands of children across sub-Saharan Africa die from infections that are both preventable and treatable. Interventions like azithromycin distribution can significantly reduce child mortality in high-burden settings.

That’s why today, we’re announcing a $7 million supply agreement to support the delivery of quality-assured medicines through the Resiliency through Azithromycin for Children (REACH) programme in Burkina Faso.

Through the agreement, Axmed will support the country’s participation in the REACH programme, helping to expand coverage and reduce preventable child deaths. 

𝗢𝘃𝗲𝗿 𝘁𝗵𝗲 𝗻𝗲𝘅𝘁 𝘁𝗵𝗿𝗲𝗲 𝘆𝗲𝗮𝗿𝘀, 𝘂𝗽 𝘁𝗼 𝟭𝟲 𝗺𝗶𝗹𝗹𝗶𝗼𝗻 𝗱𝗼𝘀𝗲𝘀 𝗼𝗳 𝗲𝘀𝘀𝗲𝗻𝘁𝗶𝗮𝗹 𝗺𝗲𝗱𝗶𝗰𝗶𝗻𝗲𝘀 𝘄𝗶𝗹𝗹 𝗯𝗲 𝗱𝗲𝗹𝗶𝘃𝗲𝗿𝗲𝗱 𝘁𝗼 𝗰𝗵𝗶𝗹𝗱𝗿𝗲𝗻 𝘂𝗻𝗱𝗲𝗿 𝗳𝗶𝘃𝗲 𝗮𝗰𝗿𝗼𝘀𝘀 𝘁𝗵𝗲 𝗰𝗼𝘂𝗻𝘁𝗿𝘆.

This is what country-led, system-enabled access looks like.

Read more at the link in our bio.

Address

Boston, MA

Website

Alerts

Be the first to know and let us send you an email when Axmed posts news and promotions. Your email address will not be used for any other purpose, and you can unsubscribe at any time.

Shortcuts

Share

Category